Lyell Immunopharma (LYEL) shares were down 9% in recent Wednesday trading after BofA downgraded the company's stock to underperform from buy and cut its price target to $1 from $6.
The company's trading volume stood at more than 1.4 million shares against a daily average of over 959,000.
Price: 0.86, Change: -0.09, Percent Change: -9.03